Article

cleveland.com on 2021-04-13 20:12

Dr. Anthony Fauci responds to concerns over blood clots and Johnson & Johnson vaccine: ‘It’s less than one in a million’

Related news

Blood clots should be listed as rare Johnson & Johnson side effect - EMA timesofmalta.com
Malta , France , Europe , United States
EU reviews Johnson & Johnson vaccine after blood clots israelnationalnews.com
Israel , New York , United States , Europe
MDr. Anthony Fauci responds to rebuke by Rand Paul: ‘I give advice according to the best scientific evidence’marketwatch.com
Europe , China , Oregon , Kentucky , Infectious Diseases
Who is Dr. Anthony Fauci?Fox News
New York , Arecibo , United States , The Hill , Washington
Teen needs 3 brain surgeries after blood clots linked to Johnson & Johnson vaccine nj.com
Southern California , Dominican Republic , Las Vegas , Clark , Nevada
PTeen receives three brain surgeries related to blood clots after Johnson & Johnson COVID-19 vaccine pennlive.com
Southern California , Dominican Republic , Las Vegas , Clark , Nevada
EU regulator finds link between Johnson & Johnson shot and blood clots Denver Post
China , Russia , Germany , Norway , Croatia
Federal agencies recommend ‘pause’ for Johnson & Johnson vaccine over reports of blood clots Alaska Dispatch News
United Kingdom , Baltimore
WJohnson & Johnson vaccine and blood clots: A risk, if it exists, is tiny wirehub.medianewsgroup.com
Florida , Norway , Germany , Ohio , New York
SEuropean drug watchdog backs Johnson & Johnson vaccine despite ‘possible link’ to blood clots scmp.com
Europe
EU medicines regulator finds possible link between Johnson & Johnson vaccine and blood clots CNN
United States , Europe
Johnson & Johnson vaccine to remain in limbo while officials seek more data on rare blood clots Alaska Dispatch News
Germany , Norway , Poland , Philadelphia , Europe
Dangerous blood clots pose a perplexing coronavirus threat dailyherald.com
United States , Europe , China , New Hampshire , Mount Sinai
AstraZeneca vaccine linked to rare blood clots, EU regulators conclude Ars Technica
Germany , Europe , Cyprus